相关实验视频
Updated: Jun 24, 2025

07:02
Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
Published on: January 19, 2019
6.4K
在COVID-19的非常老的幸存者中长期死亡率
Christine Serratrice1, Michèle Jean2, François Herrmann3
1Division of Internal Medicine for the Aged, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.
概括
在最初的COVID-19住院治疗中幸存下来的老年人在18个月内没有经历过多的死亡率. 然而,养老院居民面临的死亡率明显更高,这表明需要有针对性的支持.
科学领域:
- 老年医学 老年医学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 第一次COVID-19浪潮不成比例地影响了老年人.
- 老年COVID-19幸存者的长期结果仍然是研究的关键领域.
- 了解出院后的死亡率对于老年护理至关重要.
研究的目的:
- 确定那些在COVID-19的急性阶段幸存下来的老年患者的18个月死亡率.
- 为了确定与这一队列中死亡率相关的风险因素.
- 评估生活状况对长期生存的影响.
主要方法:
- 进行了一项观察性队列研究.
- 包括的患者年龄在65岁或以上,并在第一波期间因COVID-19住院治疗.
- 统计分析包括费舍尔精确,曼·惠特尼U,t测试和考克斯比例危险回归.
主要成果:
- 在入院的323名患者中,有196人经过了急性阶段;34人 (17.3%) 在出院后18个月内死亡.
- 养老院住院 (HR 3.07,P = .007) 和重新住院与增加的死亡率有显著的关联.
- 根据年龄,性别,呼吸障碍或痴呆症,没有观察到生存率的显著差异.
结论:
- 与基线预期相比,18个月后,老年COVID-19幸存者没有表现出过度死亡率.
- 在养老院生活是COVID-19后住院生存率下降的重要独立风险因素.
- 调查结果强调了机构住院老年人的脆弱性,以及需要针对性地制定出院后护理策略.
相关概念视频
Actuarial Approach
74
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
74
Pneumonia III: Complications and Assessment
200
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
200
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
COPD: Pathogenesis and Clinical Features
259
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
259
Acute Respiratory Failure-II
208
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
208
Acute Respiratory Failure-III
174
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
174

